In the current consolidation phase for pharma sector, investors should focus on winners for the long term. Cipla, with its leadership in inhalation, focus on green chemistry and potential deployment of cash savings for new growth drivers, warrants attention. We tell you why.
first published: Aug 6, 2021 07:40 pm
A collection of the most-viewed Moneycontrol videos.
Indian stocks Vs Gold, Silver, Global equities: Manish Chokhani on where to sow, where to harvest
Can Nifty Reclaim 25,400 After Strong Comeback; Infosys, Axis, Eternal In Focus|Opening Bell Live
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
